Ravandi, F., Ritchie, E. K., Sayar, H., Lancet, J. E., Craig, M. D., Vey, N., … Schiller, G. J. (2015). ALLOGENEIC TRANSPLANT IN PATIENTS >= 60 YEARS OF AGE WITH FIRST RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA AFTER TREATMENT WITH VOSAROXIN OR PLACEBO PLUS CYTARABINE: RESULTS FROM VALOR. In HAEMATOLOGICA (Vol. 100, pp. 42–42). Vienna, AUSTRIA: FERRATA STORTI FOUNDATION.

Ravandi, F., E. K. Ritchie, H. Sayar, J. E. Lancet, M. D. Craig, N. Vey, S. A. Strickland, et al. “ALLOGENEIC TRANSPLANT IN PATIENTS >= 60 YEARS OF AGE WITH FIRST RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA AFTER TREATMENT WITH VOSAROXIN OR PLACEBO PLUS CYTARABINE: RESULTS FROM VALOR.” In HAEMATOLOGICA, 100:42–42. FERRATA STORTI FOUNDATION, 2015.

Ravandi F, Ritchie EK, Sayar H, Lancet JE, Craig MD, Vey N, et al. ALLOGENEIC TRANSPLANT IN PATIENTS >= 60 YEARS OF AGE WITH FIRST RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA AFTER TREATMENT WITH VOSAROXIN OR PLACEBO PLUS CYTARABINE: RESULTS FROM VALOR. In: HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2015. p. 42–42.

Ravandi, F., et al. “ALLOGENEIC TRANSPLANT IN PATIENTS >= 60 YEARS OF AGE WITH FIRST RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA AFTER TREATMENT WITH VOSAROXIN OR PLACEBO PLUS CYTARABINE: RESULTS FROM VALOR.” HAEMATOLOGICA, vol. 100, FERRATA STORTI FOUNDATION, 2015, pp. 42–42.

Ravandi F, Ritchie EK, Sayar H, Lancet JE, Craig MD, Vey N, Strickland SA, Erba HP, Pigneux A, Horst HA, Recher C, Klimek VM, Odenike O, Craig AR, Ward R, Smith JA, Kantarjian HM, Stuart RK, Schiller GJ. ALLOGENEIC TRANSPLANT IN PATIENTS >= 60 YEARS OF AGE WITH FIRST RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA AFTER TREATMENT WITH VOSAROXIN OR PLACEBO PLUS CYTARABINE: RESULTS FROM VALOR. HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2015. p. 42–42.